Why is the CSL share price defying today’s sell-off?

Two happy scientists analysing test results.Two happy scientists analysing test results.

The CSL Limited (ASX: CSL) share price is in the green on Thursday despite the broader market’s struggles.

At the time of writing, shares in the healthcare giant are trading for $272.33, 0.53% higher than their previous close.

Meanwhile, the S&P/ASX 200 Index (ASX: XJO) has tumbled 1.12%, and the All Ordinaries Index (ASX: XAO) has slipped 1.17%.

Let’s take a look at what might be helping CSL’s stock to dodge today’s carnage.

What’s buoying the CSL share price?

The CSL share price is outperforming on Thursday, as is its home sector – the S&P/ASX 200 Health Care Index (ASX: XHJ).

The health care sector has spent much of the day in the green but has just edged into the red by 0.06%.

And CSL isn’t the sector’s best performer.

It’s being beaten by ASX 200 staple Ramsay Health Care Limited (ASX: RHC). The stock is boasting a 0.71% gain right now.

Though, it’s not all sunshine for the healthcare sector on Thursday.

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is plunging 5.97%, making it one of the worst performers on the ASX 200.

Despite today’s gains, the CSL share price is still 8.18% lower than it was at the start of 2022. That’s compared to the ASX 200’s 7.22% year-to-date slip.

Meanwhile, the healthcare index has plummeted 12.22% this year so far.

The post Why is the CSL share price defying today’s sell-off? appeared first on The Motley Fool Australia.

Should you invest $1,000 in CSL right now?

Before you consider CSL, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

More reading

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/flVv8Rt

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s